DPP4 and atherosclerosis: A recent study demonstrated CD26 inhibition reduces atherosclerosis and inflammation via a reduction in macrophage migration and regulating dendritic cell (DC)/macrophage-mediated adipose tissue inflammation in cardiovascular disease [31].